Abstract
A series of quaternary ammonium fluoroquinolones was obtained by exhaustive methylation of the amine groups present at the 7-position of fluoroquinolones, including ciprofloxacin, enoxacin, gatifloxacin, lomefloxacin, and norfloxacin. The synthesized molecules were tested for their antibacterial and antibiofilm activities against Gram-positive and Gram-negative human pathogens, i.e. Staphylococcus aureus and Pseudomonas aeruginosa. The study showed that the synthesized compounds are potent antibacterial agents (MIC values at the lowest 6.25 μM) with low cytotoxicity in vitro as assessed on the BALB 3T3 mouse embryo cell line. Further experiments proved that the tested derivatives are able to bind to the DNA gyrase and topoisomerase IV active sites in a fluoroquinolone-characteristic manner. The most active quaternary ammonium fluoroquinolones, in contrast to ciprofloxacin, reduce the total biomass of P. aeruginosa ATCC 15442 biofilm in post-exposure experiments. The latter effect may be due to the dual mechanism of action of the quaternary fluoroquinolones, which also involves disruption of bacterial cell membranes. IAM-HPLC chromatographic experiments with immobilized artificial membranes (phospholipids) showed that the most active compounds were those with moderate lipophilicity and containing a cyclopropyl group at the N1 nitrogen atom in the fluoroquinolone core.
Original language | English |
---|---|
Article number | 115373 |
Number of pages | 14 |
Journal | European Journal of Medicinal Chemistry |
Volume | 254 |
DOIs | |
Publication status | Published - 5 Jun 2023 |
Publication type | A1 Journal article-refereed |
Funding
This work was supported by the Polish National Agency for Academic Exchange [grant number PPN/BEK/2019/1/00217]; the Academy of Finland (grant no. 321551), and Medical University of Gdańsk (Poland) subsidies. We thank OpenEye Scientific Software, Santa Fe, NM., for free academic licenses for the use of their software, and the DDCB core facility supported by the University of Helsinki (HiLIFE) and Biocenter Finland for access to bioactivity screening facilities.The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Joanna Fedorowicz reports financial support was provided by Polish National Agency for Academic Exchange. Paivi Tammela reports financial support was provided by Academy of Finland. Joanna Fedorowicz reports financial support was provided by Medical University of Gdansk. Jaroslaw Saczewski reports equipment, drugs, or supplies was provided by OpenEye Scientific Software. Paivi Tammela reports equipment, drugs, or supplies was provided by University of Helsinki. This work was supported by the Polish National Agency for Academic Exchange [grant number PPN/BEK/2019/1/00217 ]; the Academy of Finland (grant no. 321551 ), and Medical University of Gdańsk (Poland) subsidies . We thank OpenEye Scientific Software, Santa Fe, NM., for free academic licenses for the use of their software, and the DDCB core facility supported by the University of Helsinki (HiLIFE) and Biocenter Finland for access to bioactivity screening facilities.
Keywords
- Antibacterial activity
- Antibiofilm activity
- Molecular docking
- Pseudomonas aeruginosa
- Quaternary ammonium compounds
- Quinolone
Publication forum classification
- Publication forum level 2
ASJC Scopus subject areas
- Pharmacology
- Drug Discovery
- Organic Chemistry
Fingerprint
Dive into the research topics of 'Antibacterial and antibiofilm activity of permanently ionized quaternary ammonium fluoroquinolones'. Together they form a unique fingerprint.Datasets
-
CCDC 2195742: Experimental Crystal Structure Determination
Fedorowicz, J. (Contributor), Cruz, C. D. (Contributor), Morawska, M. (Contributor), Ciura, K. (Contributor), Gilbert-Girard, S. (Contributor), Mazur, L. (Contributor), Mäkkylä, H. (Contributor), Ilina, P. (Contributor), Savijoki, K. (Creator), Fallarero, A. (Contributor), Tammela, P. (Contributor) & Sączewski, J. (Contributor), Cambridge Crystallographic Data Centre, 8 Aug 2023
DOI: 10.5517/ccdc.csd.cc2cpvdb
Dataset